Related Experiment Video
Updated: May 28, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Replication of Crohn's disease-associated AIEC within macrophages is dependent on TNF-α secretion
Marie-Agnès Bringer1, Elisabeth Billard, Anne-Lise Glasser
1Clermont Université, Université d'Auvergne, JE2526, Clermont-Ferrand, France.
Abstract:
Adherent and invasive Escherichia coli (AIEC) associated with Crohn's disease are able to survive and to replicate extensively in active phagolysosomes within macrophages. AIEC-infected macrophages release large amounts of tumour necrosis factor-alpha (TNF-α) and do not undergo cell death. The aim of the present study was to determine what benefit AIEC bacteria could gain from inducing the release of large amounts of TNF-α by infected macrophages and to what extent the neutralization of TNF-α could affect AIEC intramacrophagic replication. Our results showed that the amount of TNF-α released by infected macrophages is correlated with the load of intramacrophagic AIEC bacteria and their intracellular replication. TNF-α secretion was not related to the number of bacteria entering host cells because when the number of bacteria internalized in macrophage was decreased by blocking lipid raft-dependent and clathrin-coated pits-dependent endocytosis, the amount of TNF-α secreted by infected macrophages was not modified. Interestingly, dose-dependent increases in the number of intracellular AIEC LF82 bacteria were observed when infected macrophages were stimulated with exogenous TNF-α, and neutralization of TNF-α secreted by AIEC-infected macrophages using anti-TNF-α antibodies induced a significant decrease in the number of intramacrophagic bacteria. These results indicate that AIEC bacteria use TNF-α as a Trojan horse to ensure their intracellular replication because replication of AIEC bacteria within macrophages induces the release of TNF-α, which in turn increases the intramacrophagic replication of AIEC. Neutralizing TNF-α secreted by infected macrophages may represent an effective strategy to control AIEC intracellular replication.
Insights
Adherent and invasive Escherichia coli (AIEC) hijack tumor necrosis factor-alpha (TNF-α) to replicate within macrophages. Neutralizing TNF-α significantly reduces AIEC bacterial load, offering a potential therapeutic strategy for Crohn's disease.
Area of Science:
- Microbiology
- Immunology
- Gastroenterology
Background:
- Adherent and invasive Escherichia coli (AIEC) are linked to Crohn's disease.
- AIEC survive and replicate within macrophages, inducing significant tumor necrosis factor-alpha (TNF-α) release without causing cell death.
Purpose of the Study:
- To investigate the role of TNF-α in AIEC intracellular replication.
- To assess the impact of TNF-α neutralization on AIEC intramacrophagic load.
Main Methods:
- Quantifying TNF-α release from infected macrophages.
- Correlating TNF-α levels with intracellular AIEC replication.
- Modulating endocytosis to assess TNF-α secretion independence from bacterial entry.
- Stimulating macrophages with exogenous TNF-α to observe AIEC growth.
- Neutralizing endogenous TNF-α using antibodies to evaluate effects on AIEC replication.
Main Results:
- TNF-α release by macrophages is directly correlated with intracellular AIEC replication, not initial bacterial entry.
- Exogenous TNF-α promotes dose-dependent replication of AIEC within macrophages.
- Neutralization of macrophage-derived TNF-α significantly reduces intramacrophagic AIEC numbers.
Conclusions:
- AIEC exploits TNF-α as a "Trojan horse" to promote its intracellular replication within macrophages.
- Targeting TNF-α represents a promising therapeutic avenue to control AIEC persistence in Crohn's disease.
More Related Videos
07:34Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
11:48Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease II: Ulcerative Colitis
Chronic Inflammation: Introduction
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...